Assignee
SYDNEXIS INC
US·19 granted patents·16 pending applications·217 citations·filing 2015–2025
Top patents by PatentIndex Score
35 records- 0198US11596625B2Ophthalmic compositionSYDNEXIS INC·Filed 2020·Granted Mar 7, 2023·9 cites·20 claims
- 0298US10953002B2Ophthalmic compositionSYDNEXIS INC·Filed 2020·Granted Mar 23, 2021·11 cites·15 claims
- 0398US10940145B2Ophthalmic compositionSYDNEXIS INC·Filed 2020·Granted Mar 9, 2021·19 cites·23 claims
- 0498US10888557B2Ophthalmic compositionSYDNEXIS INC·Filed 2020·Granted Jan 12, 2021·20 cites·23 claims
- 0598US10813923B1Ophthalmic compositionSYDNEXIS INC·Filed 2020·Granted Oct 27, 2020·11 cites·15 claims
- 0698US9421199B2Ophthalmic compositionSYDNEXIS INC·Filed 2015·Granted Aug 23, 2016·45 cites·27 claims
- 0797US11052095B2D2O stabilized pharmaceutical formulationsSYDNEXIS INC·Filed 2020·Granted Jul 6, 2021·7 cites·14 claims
- 0897US10864208B2Ophthalmic compositionSYDNEXIS INC·Filed 2018·Granted Dec 15, 2020·7 cites·32 claims
- 0997US10842787B2Ophthalmic compositionSYDNEXIS INC·Filed 2016·Granted Nov 24, 2020·15 cites·19 claims
- 1097US10201534B2Ophthalmic compositionSYDNEXIS INC·Filed 2018·Granted Feb 12, 2019·19 cites·30 claims
- 1197US10076515B2Ophthalmic CompositionSYDNEXIS INC·Filed 2017·Granted Sep 18, 2018·16 cites·20 claims
- 1297US9770447B2Ophthalmic compositionSYDNEXIS INC·Filed 2016·Granted Sep 26, 2017·21 cites·19 claims
- 1396US11896588B2Ophthalmic compositionSYDNEXIS INC·Filed 2022·Granted Feb 13, 2024·2 cites·20 claims
- 1495US11883390B2Ophthalmic compositionSYDNEXIS INC·Filed 2022·Granted Jan 30, 2024·1 cites·20 claims
- 1595US11382909B2Ophthalmic compositionSYDNEXIS INC·Filed 2019·Granted Jul 12, 2022·4 cites·25 claims
- 1694US11890277B2Ophthalmic compositionSYDNEXIS INC·Filed 2022·Granted Feb 6, 2024·1 cites·20 claims
- 1792US11052094B2D2O stabilized pharmaceutical formulationsSYDNEXIS INC·Filed 2016·Granted Jul 6, 2021·8 cites·28 claims
- 1891US2024398705A1Ophthalmic compositionSYDNEXIS INC·Filed 2024·Application pending·0 cites
- 1989US12070466B2D2O stabilized pharmaceutical formulationsSYDNEXIS INC·Filed 2021·Granted Aug 27, 2024·1 cites·18 claims
- 2088US2024165098A1Ophthalmic compositionSYDNEXIS INC·Filed 2023·Application pending·0 cites
- 2188US2025275983A1D2o stabilized pharmaceutical formulationsSYDNEXIS INC·Filed 2024·Application pending·0 cites
- 2285US2022409604A1Ophthalmic compositionSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 2385US2022409603A1Ophthalmic compositionSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 2485US2022409605A1Ophthalmic compositionSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 2585US2025255810A1Ophthalmic compositionSYDNEXIS INC·Filed 2025·Application pending·0 cites
- 2683US2022265632A1Ophthalmic compositionSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 2783US2025186251A1Ophthalmic composition and delivery device thereofSYDNEXIS INC·Filed 2024·Application pending·0 cites
- 2883US2022265631A1Ophthalmic compositionSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 2982US2022378775A1Ophthalmic compositionSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 3080US2023381016A1Ophthalmic composition and delivery device thereofSYDNEXIS INC·Filed 2023·Application pending·0 cites
- 3177US12168017B2D2O stabilized pharmaceutical formulationsSYDNEXIS INC·Filed 2021·Granted Dec 17, 2024·0 cites·20 claims
- 3265US2020345542A1Ophthalmic composition and delivery device thereofSYDNEXIS INC·Filed 2018·Application pending·0 cites
- 3360US2024139166A1Ophthalmic compositions for presbyopiaSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 3455US2023041788A1Ophthalmic compositions comprising d2oSYDNEXIS INC·Filed 2020·Application pending·0 cites
- 3536US2016009705A1Ophthalmic compositionSYDNEXIS INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →